135 related articles for article (PubMed ID: 15033446)
1. An anti-proliferative gene BTG1 regulates angiogenesis in vitro.
Iwai K; Hirata K; Ishida T; Takeuchi S; Hirase T; Rikitake Y; Kojima Y; Inoue N; Kawashima S; Yokoyama M
Biochem Biophys Res Commun; 2004 Apr; 316(3):628-35. PubMed ID: 15033446
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiogenesis in vitro by alphav integrin-directed antisense oligonucleotides.
Kronenwett R; Gräf T; Nedbal W; Weber M; Steidl U; Rohr UP; Möhler T; Haas R
Cancer Gene Ther; 2002 Jul; 9(7):587-96. PubMed ID: 12082459
[TBL] [Abstract][Full Text] [Related]
3. Identification of endothelial cell genes expressed in an in vitro model of angiogenesis: induction of ESM-1, (beta)ig-h3, and NrCAM.
Aitkenhead M; Wang SJ; Nakatsu MN; Mestas J; Heard C; Hughes CC
Microvasc Res; 2002 Mar; 63(2):159-71. PubMed ID: 11866539
[TBL] [Abstract][Full Text] [Related]
4. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells.
Iwasaka C; Tanaka K; Abe M; Sato Y
J Cell Physiol; 1996 Dec; 169(3):522-31. PubMed ID: 8952701
[TBL] [Abstract][Full Text] [Related]
5. Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis.
Carson-Walter EB; Hampton J; Shue E; Geynisman DM; Pillai PK; Sathanoori R; Madden SL; Hamilton RL; Walter KA
Clin Cancer Res; 2005 Nov; 11(21):7643-50. PubMed ID: 16278383
[TBL] [Abstract][Full Text] [Related]
6. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
7. In vitro model of angiogenesis using a human endothelium-derived permanent cell line: contributions of induced gene expression, G-proteins, and integrins.
Bauer J; Margolis M; Schreiner C; Edgell CJ; Azizkhan J; Lazarowski E; Juliano RL
J Cell Physiol; 1992 Dec; 153(3):437-49. PubMed ID: 1280276
[TBL] [Abstract][Full Text] [Related]
8. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
[TBL] [Abstract][Full Text] [Related]
9. Serum derived from multiple trauma patients promotes the differentiation of endothelial progenitor cells in vitro: possible role of transforming growth factor-beta1 and vascular endothelial growth factor165.
Henrich D; Hahn P; Wahl M; Wilhelm K; Dernbach E; Dimmeler S; Marzi I
Shock; 2004 Jan; 21(1):13-6. PubMed ID: 14676678
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human corneal epithelial production of fibrotic mediator TGF-beta2 by basement membrane-like extracellular matrix.
LaGier AJ; Yoo SH; Alfonso EC; Meiners S; Fini ME
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1061-71. PubMed ID: 17325147
[TBL] [Abstract][Full Text] [Related]
11. Extracellular angio-associated migratory cell protein plays a positive role in angiogenesis and is regulated by astrocytes in coculture.
Beckner ME; Jagannathan S; Peterson VA
Microvasc Res; 2002 May; 63(3):259-69. PubMed ID: 11969303
[TBL] [Abstract][Full Text] [Related]
12. Reorganization of endothelial cord-like structures on basement membrane complex (Matrigel): involvement of transforming growth factor beta 1.
Kuzuya M; Kinsella JL
J Cell Physiol; 1994 Nov; 161(2):267-76. PubMed ID: 7962111
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
14. Tgf-beta antisense therapy increases angiogenic potential in human keratinocytes in vitro.
Riedel K; Riedel F; Goessler UR; Germann G; Sauerbier M
Arch Med Res; 2007 Jan; 38(1):45-51. PubMed ID: 17174722
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of TGF-beta by antisense oligonucleotides modulates expression of VEGF and increases angiogenic potential in isolated fibroblasts from radiated skin.
Riedel K; Koellensperger E; Ryssel H; Riedel F; Goessler UR; Germann G; Kremer T
Int J Mol Med; 2008 Oct; 22(4):473-80. PubMed ID: 18813854
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta antisense oligonucleotides reduce mRNA expression of matrix metalloproteinases in cultured wound-healing-related cells.
Philipp K; Riedel F; Germann G; Hörmann K; Sauerbier M
Int J Mol Med; 2005 Feb; 15(2):299-303. PubMed ID: 15647847
[TBL] [Abstract][Full Text] [Related]
17. The homeobox gene Gax inhibits angiogenesis through inhibition of nuclear factor-kappaB-dependent endothelial cell gene expression.
Patel S; Leal AD; Gorski DH
Cancer Res; 2005 Feb; 65(4):1414-24. PubMed ID: 15735029
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial zinc finger 1 is involved in the regulation of angiogenesis: possible contribution of stathmin/OP18 as a downstream target gene.
Miyashita H; Kanemura M; Yamazaki T; Abe M; Sato Y
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):878-84. PubMed ID: 15031128
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of PEDF expression by ribozyme transgene in endothelial and lung cancer cells and its impact on angiogenesis in vitro.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Oncol Rep; 2005 Dec; 14(6):1615-9. PubMed ID: 16273265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
